Christine Dosquet

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms.

Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms.

Journal: Blood
Published: December 14, 2020

Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurements.

Anemia and hemodilution: analysis of a single center cohort based on 2,858 red cell mass measurements.

Journal: Haematologica
Published: June 05, 2020

Covid-19: care protocols or research protocols?

Covid-19: care protocols or research protocols?

Journal: Medecine sciences : M/S
Published: May 27, 2020

Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms.

Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms.

Journal: Cancers
Published: March 03, 2020

Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.

Masked polycythemia vera: analysis of a single center cohort of 2480 red cell masses.

Journal: Haematologica
Published: August 16, 2019

Autologous111 Indium-oxinate-labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor-agonists.

Autologous111 Indium-oxinate-labelled platelet sequestration study in patients with immune thrombocytopenia treated by thrombopoietin receptor-agonists.

Journal: British journal of haematology
Published: April 06, 2019

When hemolysis masks polycythemia vera.

When hemolysis masks polycythemia vera.

Journal: Clinical case reports
Published: April 24, 2018

Towards a personalized pretransplantation conditioning in patients with myelodysplastic syndromes

Towards a personalized pretransplantation conditioning in patients with myelodysplastic syndromes

Journal: Medecine sciences : M/S
Published: February 01, 2018

Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study.

Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study.

Journal: Haematologica
Published: September 22, 2017

Role of the microenvironment in myeloid malignancies.

Role of the microenvironment in myeloid malignancies.

Journal: Cellular and molecular life sciences : CMLS
Published: August 08, 2017

Preclinical modeling of myelodysplastic syndromes.

Preclinical modeling of myelodysplastic syndromes.

Journal: Leukemia
Published: February 24, 2017

Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of 18F-FLT PET.

Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of 18F-FLT PET.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 28, 2016
Showing 1-12 of 18

Last Updated: 09/26/2026